Index A embolization agent and preprocedure AAST. See American Association rupture , 99 for Surgery of Trauma (AAST) emergency situations , 99 Abdominopelvic tumors endovascular treatment , 99 adrenal , 423 extrahepatic proximal segment , 98 pelvic ( see Pelvic tumors) ischemic tolerance problems , 99 Adjuvant medications , 34 periarthritis nodosa/fi bro muscular AITP. See Autoimmune thrombocytopenic dysplasia , 100 purpura (AITP) technique , 98 American Association for Surgery visceral aneurysms , 99 of Trauma (AAST) and pseudoaneurysms abdominal visceral injuries , 357 catheterization , 161 “Baltimore” codifi cation , 360 indications , 161–162 grade I and II lesions , 360 outcomes , 162 grade IV and V , 358 visceral arteries , 160–161 organ injury scale , 388 Angiomyolipoma (AML) parietal cephalic impacts diagnosis , 233 and abdominal pain , 375 preventive embolization , 234 splenic traumatic injury , 380 symptomatic , 233 AML. See Angiomyolipoma (AML) Antibiotic prophylaxis , 37–39 Amplatzer vascular plugs Aortography (AVPs) , 20, 21, 81 infrarenal aorta , 316 Anesthesia and sedation ovarian arteries , 311 allergies , 34 vascularization, atonic uterus , 316 dosage , 35 Arteriovenous malformations (AVM) droperidol, propofol anesthesia , 408 and etomidate , 36 coaxial microcatheter , 408 intravascular injection , 34 embolization , 406 midazolam , 36 ethanol , 408 neuroleptanalgesia , 35 fl ow and type, malformation , 405 pain control , 36–37 hypoechoic serpiginous structures , plexus blocks , 35 406–407 sufentanil , 35–36 middle sacral artery , 408, 420 Aneurysms pulmonary pressure , 409 hepatic artery pulsatile mass , 406 P. Chabrot, L. Boyer (eds.), Embolization, 445 DOI 10.1007/978-1-4471-5182-1, © Springer-Verlag London 2014 446 Index Autoimmune thrombocytopenic purpura embospheres , 326 (AITP) , 164 gynecological consultation , 327 AVM. See Arteriovenous malformations hospital length , 328 (AVM) multidisciplinary discussion , 330 AVPs. See Amplatzer vascular plugs (AVPs) pelvic MRI , 329 post-embolization syndrome , 326 pre-and post-procedural phases , 325 B pregnancy and fertility , 330–331 BA. See Bronchial artery (BA) re-intervention procedures , 328–329 Balloon-occluded retrograde transvenous success rate and complications , 327–328 obliteration (BRTO) therapeutic protocol , 325–326 vs. endoscopic sclerosis , 426 uterine reperfusion , 326 portacaval gastrorenal shunt , 425 CurUFE. See Curative uterine fi broid renal vein , 426 embolization (CurUFE) Barcelona Clinic Liver Classifi cation (BCLC) , 121, 123 BCLC. See Barcelona Clinic Liver D Classifi cation (BCLC) DEB. See Drug-eluting beads (DEB) Bronchial artery (BA) Double systemic arterial , 69 adenocarcinoma , 75–76 Drug-eluting beads (DEB) , 117, 122 anastomosis , 73 angio and embolization techniques , 65–66 aorta , 64 E arterial wall erosion , 63 Embolization complications , 67, 70 anastomotic network , 357 CT , 64 blood transfusions , 357 ectopic and aberrant BA , 71 catheterization pathway and occlusion systemic hemorrhages , 67 type , 31 BRTO. See Balloon-occluded retrograde head trauma , 378–379 transvenous obliteration (BRTO) hemodynamic collapse , 385–387 hepatic trauma (see Hepatic trauma) highway accident, limb fractures , 380–381 C hypogastric aneurysms , 215 CA. See Celiac artery (CA) imaging work-up , 356 Carotid artery, cancerology , 50–51, 56 initial assessment and resuscitation , 355 Carotid blowout syndrome , 51–52, 57 liver injury and blush , 371–372 Catheterization devices morphological assessment , 367–370 frequently used , 23, 24 non-aneurysmal hypogastric arteries , guide wires , 24 215–216 hydrophilic catheters , 23 parenchymal embolizations ( see microcatheters , 23–24 Parenchymal embolizations) sheaths and catheters , 23 parietal cephalic impacts and abdominal Celiac artery (CA) , 195–196 pain , 375–377 Closure devices pelvic hematoma , 358 angiographic series , 25 polytrauma patients , 355 description , 25 renal traumatisms , 361–363 double-guided technique , 25–26 RPH , 357–358 Computed tomography (CT) scan , 81, 89–91, solid organs , 357 97, 100 splenic traumas ( see Splenic traumas) Curative uterine fi broid embolization terminal arterial tree organs , 356 (CurUFE) traumatic lesions , 356 catheterization diffi culties and spasms , 326 truncal embolizations , 31–32 contraindications and indications , 330 upper quadrant pain , 373–374 control angiography , 326 varicocele ( see Varicoceles) Index 447 vascularization type , 31 G vessel occlusion , 357 Gastrointestinal (GI) tract hemorrhages Endocrine tumors (ET) , 124 arteriography , 182 Endoleaks. See Endovascular cholecystectomy , 185 abdominal aortic aneurysm chronic lymphoid leukemia , 183–184 repair (EVAR) coloscopy , 187 Endotension , 292 complications , 179–180 Endovascular abdominal aortic aneurysm embolization , 176–177 repair (EVAR) esogastroduodenal endoscopy , 174 aortic aneurysms , 291 fi broscopy , 189–190 arteriovenous malformations , 295 hematemesis , 181 blood pressure , 291 hepatic segmentectomy , 183 endoleaks classifi cation , 291–292 iodine , 174 end-stage renal failure , 297–300 lower hemorrhages , 178, 179 indications , 296 necrotico-hemorrhagic acute pancreatitis , infrarenal AAA , 302–305 186 optimal occlusion agent , 296 PHT , 173 radiological anatomy , 292 radiological anatomy , 174–175 reintervention rate , 295 rectum cancer , 190–193 type I endoleaks , 292–293 upper hemorrhages , 178, 179 type II endoleaks ( see Type II endoleaks) urinary catheterization , 176 Epistaxes angiography , 48–49 anterior gauze plugging and endoscopic H electrocoagulation , 45 HCC. See Hepatocellular carcinoma (HCC) controlled hemorrhage, hemodynamic Hemarthrosis, knee arthroplasty instability , 48 conservative management , 429 description , 44 description , 428 endovascular treatment , 46–47, 55 synovectomy , 428 environment, indications and patient’s Hematological diseases situation , 47 AITP , 164 occlusion material , 47 myeloproliferative diseases , organic causes , 44 164–165 post-embolization neuropathies , 50 thalassemia , 165 refractory epistaxes etiologies , 44 Hematomas relevant radiological anatomy , anticoagulants , 259 45, 54 indications , 261–262 surgical treatment , 45–46 non-Hodgkin lymphoma , 266 systemic complications , 49 outcomes , 261 ET. See Endocrine tumors (ET) rectus sheath , 260 Ethylene vinyl alcohol (EVA) retroperitoneal hematoma , 263 instructions , 12 retroperitoneum and psoas , 260 onyx , 11–12 rhythmic cardiopathy , 264–265 technical characteristics , 11 Seldinger technique , 260–261 tumor neovascularizations , 12 ultrasound , 259–260 EVA. See Ethylene vinyl alcohol (EVA) Hemoptysis (H) EVAR. See Endovascular abdominal aortic aortogram, catheterization and post-embo aneurysm repair (EVAR) angiogram , 72 arterial bleeding ( see Systemic arterial bleeding) F bronchial circulation , 63 Fanconi syndrome , 79 bronchial hypervascularization , 73–74 FLR. See Future liver remnant (FLR) celiac trunk (CT) , 64 Future liver remnant (FLR) , 135 description , 63 448 Index Hemoptysis (H) ( cont.) chemoembolization, loaded double systemic arterial and pulmonary microspheres , 117 embolization, 69 cone beam CT , 119 multidetector CT (MDCT) , 64 HepaSphere microparticles , 118 percutaneous endovascular hepatic infusions, chemotherapy , embolization , 64 116–117 pulmonary arterial bleedings , 67–68 hepatic intra-arterial chemotherapy , 116 radiological anatomy , 64–65 inter-cure , 119 Hemorrhages, ENT lipiodol chemoembolization , 117 arterial embolization and hemorrhages , 43 Seldinger’s technique , 118 carotid blowout , 51–52, 57 randomized controlled trials , 121–122 epistaxes ( see Epistaxes) TACE , 131 external carotid artery, cancerology , 50–51, technical variations and evolutions 56 drugs , 123 microcatheterism technique , 53 endovascular treatments , 123 Rendu-Osler disease , 52 radioembolization , 122–123 tumors , 52, 58 radiosensitization agents , 123 Hepatic artery embolizations treatment , 141 aneurysms , 98–100 Hereditary hemorrhagic telangiectasia arterial segmentation, liver , 104 (HHT) , 79, 81 carcinoid secreting liver metastasis , 107 HHT. See Hereditary hemorrhagic CT , 104 telangiectasia (HHT) hypochondrium pain , 105–106 Hypersplenism liver traumatisms , 97–98 indications and outcomes , 163–164 liver tumors, hemorrhaging situations , PHT , 162 101–103 technique , 163 malignant pancreatic insulinoma , Hypogastric arteries 108–111 aneurysms , 213–214 radiological anatomy , 95–96 aortobifemoral bypass , 222–225 spontaneous hemoperitoneum , 100–101 aortoiliac aneurysms , 215–216 technique , 96–97 axial transverse , 218 vascular and traumatic disease , 95 embolization techniques , 214–215 Hepatic trauma endovascular techniques , 216 indications , 358–359 endovascular treatment , 213 morphological imaging , 359 iliac and hypogastric arteries , 219–221 mortality rate , 359 outcomes , 216 Hepatocellular carcinoma (HCC) radiological anatomy , 214 adjuvant treatment , 121 retrograde injection , 217 BCLC treatment algorithm , 121 and cholangiocarcinomas , 140 complication , 127 I contraindications , 120 ICBT. See Intercostobronchial CT , 126 trunk (ICBT) description , 115–116 IIA. See Internal iliac arteries (IIA) HepaSpheres , 121–122 ILA. See Iliolumbar artery (ILA) hepatic failure , 121 Iliolumbar artery (ILA) , 293–294 hepatic transplantation , 128–130 Intercostobronchial trunk (ICBT) , indications , 120 64, 65, 71 malignant liver tumors ( see Malignant Internal iliac arteries (IIA) tumors) bilateral embolization , 311 mortality and morbidity , 121 division